New Oral Anticoagulant Agents – General Features and Outcomes in Subsets of Patients

Thrombosis and Haemostasis - Germany
doi 10.1160/th13-09-0803
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Measurement of Warfarin in the Oral Fluid of Patients Undergoing Anticoagulant Oral Therapy

PLoS ONE
Multidisciplinary
2011English

Clinical Evaluation of a New Oral Anticoagulant "Sintrom"

Circulation
Cardiovascular MedicinePhysiologyCardiology
1957English

Pcv52 - Cost Comparison: Strategies of Patients Management in Oral Anticoagulant Therapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Patients’ Perspectives Regarding Long-Term Warfarin Therapy and the Potential Transition to New Oral Anticoagulant Therapy

Therapeutic Advances in Drug Safety
Pharmacology
2014English

A Clinical Dilemma About a New Oral Anticoagulant Treatment

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2014English

Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease

Archives of Internal Medicine
2007English

Association of Atrial Fibrillation and Oral Anticoagulant Use With Perioperative Outcomes After Major Noncardiac Surgery

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2017English

Managing Oral Anticoagulant Therapy

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2001English

Standardisation of Oral Anticoagulant Treatment.

BMJ
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy